QLU

Anti-Factor Xa Activity Test System, Apixaban

Product code
QLU
Device name
Anti-Factor Xa Activity Test System, Apixaban
Device class
Class 2
21 CFR
21 CFR 864.7295
Medical specialty
Hematology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
1 (direct download)
510(k) clearances (all years, FDA)
3 (all years; only the last 3 years are listed here)

FDA classification definition

A heparin and direct oral factor Xa inhibitor drug test system is intended for the detection of heparin and direct oral factor Xa inhibitors in human specimens collected from patients taking heparin or direct oral factor Xa inhibitors. This device is intended to aid in the management of therapy in conjunction with other clinical and laboratory findings.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2024-10-10.

NumberDecision dateApplicantDevice nameSummary
K2403152024-10-10Siemens Healthcare Diagnostics Product…INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Stand…PDF

1 summaries are archived here for direct download.

Official FDA classification page: QLU
Classification and pathway per current FDA publications. Data from openFDA (CC0).